Navigation Links
Raven biotechnologies and Bioprocessing Technology Institute Announce Collaboration to Advance Discovery of Stem Cell Antibodies
Date:4/4/2008

SOUTH SAN FRANCISCO, Calif., and SINGAPORE, April 4, 2008 /PRNewswire/ -- Raven biotechnologies, inc., a privately held company focused on the discovery and development of monoclonal antibody therapeutics (MAbs) for cancer, and the Bioprocessing Technology Institute (BTI), today announced a collaboration to advance the discovery of novel cancer stem cell antibodies.

Under the terms of the agreement, Raven will license its proprietary whole cell immunization technology for use with BTI's stem cells. Raven will screen the resulting antibodies against its collection of cancer lines, including its cancer stem cell lines. Raven will have the rights to the antibodies BTI generates using Raven's immunization technology for use in cancer therapeutics and diagnostics and BTI will retain the rights to the antibodies it raises for all other stem cell therapeutic areas.

"Cancer stem cells represent a promising new source of oncology drug targets," stated George Schreiner, M.D., Ph.D., chief executive officer of Raven biotechnologies. "Our collaboration with the Bioprocessing Technology Institute's stem cell research team allows Raven to leverage its novel technology for developing monoclonal antibodies through immunization with stem cells. BTI is a world-class research institute. We anticipate that this collaboration should yield a substantial number of novel monoclonal antibodies targeting cancer stem cells suitable for development by Raven biotechnologies and its partners."

Miranda Yap, Ph.D., Executive Director of Bioprocessing Technology Institute added, "Both BTI and Raven have much to gain from this strategic alliance. It will help strengthen our respective fields of research and advance science to better human healthcare. Generation of these novel antibodies to stem cells with Raven's proprietary technology will enable the development of tools for the characterization of stem cells and importantly, these antibodies will also be valuable for th
'/>"/>

SOURCE Raven biotechnologies, inc.; Bioprocessing TechnologyInstitute
Copyright©2008 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2

Related biology technology :

1. VaxGen and Raven Terminate Merger Agreement
2. Arpida Submits New Drug Application for Intravenous Iclaprim for Treatment of Skin Infections
3. Raven Announces RAV12 Phase 1/2a Study Results To Be Presented at ASCO
4. Arpida Provides Update on Progress of New Drug Application for Intravenous Iclaprim
5. Raven biotechnologies to Provide Updates on Oncology Pipeline With Four AACR Presentations
6. VaxGen and Raven Announce Form S4 Registration Statement Declared Effective
7. Lentigen Appoints Tim Ravenscroft as Chief Executive Officer
8. First Patients Enrolled in Phase II Trial With Intravenous Iclaprim in HAP/VAP/HCAP
9. Raven biotechnologies, inc. and Wyeth Pharmaceuticals Extend Evaluation Period of Selected Raven Antibodies
10. Positive Outcome of Drug-Drug Interaction Trial With Intravenous Iclaprim
11. Epeius Biotechnologies Awarded U.S. Patent for Targeted Injectable Gene Delivery In Vivo

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)..., ST. LOUIS, Nov. 24 ... presenting at the NASDAQ OMX conference on Tuesda...US/CST. Interested parties may listen via live aud...://inve s tor.sig m a a ldrich.com/ . User.... ,, About Sigma-Aldrich: Sigma-Aldrich i...
(Date:11/24/2009)..., SHANGHAI, Nov. 24 /PRNewswire-Asia/ -- NO...p; Trademark Office (PTO) has allowed the patent a...NOD technology. , NOD technology is a hig...proteins into bio-adhesive nano-particles to enabl... injections. NOD technology is a platform technolo...
(Date:11/24/2009)..., SEATTLE, Nov. 24 Blue Marble Ene... Odessa Public Development Authority (OPDA) were r...ommunity Economic Revitalization Board (CERB) in a...,s first specialty biochemical biorefinery in Linc...ificantly speed the development of our biorefinery...
(Date:11/24/2009)..., TSX VENTURE: HTL , TORONTO, Nov. 24 /PRNew...L), formerly Calotto Capital Inc., a leading provi...the stem cell research and fertility clinic market...s for the third quarter ended September 30, 2009. ....46 million compared with $1.43 million in Q3 2008...
Breaking Biology Technology:Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Hamilton Thorne announces third quarter results 8Hamilton Thorne announces third quarter results 9Hamilton Thorne announces third quarter results 10
...grows 21 percent helping patients in more donor co...urce, one of the nation,s largest non-profit provi...use in surgical procedures, finished 2008 distribu...s into its donor communities than ever before, and... AlloSource is a leading U.S. tissue network and i...
.... 4 Air Products (NYSE: APD ) and Alter NRG Cor...nt Development Agreement (JDA) to pursue renewable... The non-exclusive agreement gives Air Products t...oprietary Westinghouse Plasma Gasification technol...ducts will initially focus on developing energy fa...
...eb. 4 To say that LifeModeler, Inc. (LMI) bucked ...ses in 2008 that are providing a platform for even... be telling the whole story. This past year will ...young company, as it literally expanded its presen...owth, to staff enhancement, to university teaching...
Other Biology Technology:AlloSource Distributes Record Amount of Tissue in 2008 2AlloSource Distributes Record Amount of Tissue in 2008 3Air Products and Alter NRG Sign JDA on Renewable Energy Projects 2Air Products and Alter NRG Sign JDA on Renewable Energy Projects 3Air Products and Alter NRG Sign JDA on Renewable Energy Projects 4While Most Companies and Industries Struggled in 2008, LifeModeler, Inc. Used Unique Products to Post Aggressive Business Gains in All Areas 2While Most Companies and Industries Struggled in 2008, LifeModeler, Inc. Used Unique Products to Post Aggressive Business Gains in All Areas 3While Most Companies and Industries Struggled in 2008, LifeModeler, Inc. Used Unique Products to Post Aggressive Business Gains in All Areas 4
(Date:11/26/2009)...harks are some of the Ocean,s most distinctive res...e this strange head shape, says Michelle McComb f...on is the shark,s vision. ,Perhaps their visual fi...says McComb, giving the sharks excellent stereovis...Comb, there were two schools of thought on this th...
(Date:11/26/2009)...heir impressive antlers, red deer have been caught...r,s antlers are much more than decorative. They ar...elling. John Currey, from The University of York, ...s of bone for over half a century and has become f...hrough a long-standing collaboration with Tomas La...
(Date:11/26/2009)...ave at last worked out a way of using recordings o...populations. This is the first time sound recordin...to accurate estimates of bird species, populations...sh Ecological Society,s Journal of Applied Ecolog...to a major advance in our ability to monitor whale...
Breaking Biology News(10 mins):Wide heads give hammerheads exceptional stereo view 2Tough yet stiff deer antler is materials scientist's dream 2Ecologists sound out new solution for monitoring cryptic species 2Forsyth Medical Center launches regions first comprehensive teleneurology program 60409 1Forsyth Medical Center launches regions first comprehensive teleneurology program 60409 2Forsyth Medical Center launches regions first comprehensive teleneurology program 60409 3New dinosaur species from Montana 10593 1New dinosaur species from Montana 10593 2GREENBioPharma Dec 2 3 2009 10591 1
... The latest evidence about the theory of evolutio...are the subject of two public programs in early Oc...ntific meeting that will draw upwards of 8,000 par...include a Public Forum and a Teacher Forum, held i... Geological Society of America, Soil Science Socie...
... MENLO PARK, Calif., Sept. 10 Promptu, a leading,...d OAG (Official Airline,Guide), a leading supplier...airline industry, announced today they have signed...ervices containing OAG flight schedule and status,...ment were not released,although the companies reve...
...ies for Use in a Wide,Range of Robotics, Artificia...VILNIUS, Lithuania, Sept. 10 Neurotechnology,( ht...-precision biometric,and object identification tec...tiSight 2.0 SDK universal object recognition techn...intelligence and computer-based vision,application...
Other Biology News:Evolution in plain language 2Evolution in plain language 3Promptu and OAG Team to Deliver Flight Schedule and Status Information on Mobile Devices 2Promptu and OAG Team to Deliver Flight Schedule and Status Information on Mobile Devices 3Neurotechnology Releases SentiSight 2.0 SDK Universal Object Recognition Technology 2Neurotechnology Releases SentiSight 2.0 SDK Universal Object Recognition Technology 3
Mouse Anti-DIPHTHERIA TOXIN (A SUBUNIT) Monoclonal Antibody, Unconjugated, Clone 8G2 from AbD Serotec
... (E-22013) provides,researchers with a sensitive a...ution. This fluorescence-based assay can detect,ly...say,measures lysozyme activity on Micrococcus lyso...degree that the fluorescence,is quenched. Lysozyme...
...s used for the synthesis of 5' capped RNA molecule...n of cap analog for a large portion of the GTP in ...incorporation of the cap structure into a large fr...lly translated more efficiently in reticulocyte ly...
iEMS Incubator/Shaker 3 module (100-120 V) from Thermo Scientific
Biology Products: